![Treatment process of patient 1 (A), patient 2 (B) and patient 3 (C).... | Download Scientific Diagram Treatment process of patient 1 (A), patient 2 (B) and patient 3 (C).... | Download Scientific Diagram](https://www.researchgate.net/publication/356895082/figure/fig1/AS:1099094944682029@1639056063702/Treatment-process-of-patient-1-A-patient-2-B-and-patient-3-C-CR-complete.png)
Treatment process of patient 1 (A), patient 2 (B) and patient 3 (C).... | Download Scientific Diagram
![Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML | Scientific Reports Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-13626-y/MediaObjects/41598_2022_13626_Fig1_HTML.png)
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML | Scientific Reports
![Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study | Leukemia Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0268-9/MediaObjects/41375_2018_268_Fig1_HTML.png)
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study | Leukemia
![Cytarabine and Idarubicin (7 plus 3) Regimen for Remission Induction of Acute Myelogenous Leukemia | Semantic Scholar Cytarabine and Idarubicin (7 plus 3) Regimen for Remission Induction of Acute Myelogenous Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c29e72c7aa7beddbf2e48a86cf6bc9929ebba9b4/2-Table1-1.png)
Cytarabine and Idarubicin (7 plus 3) Regimen for Remission Induction of Acute Myelogenous Leukemia | Semantic Scholar
![Cancers | Free Full-Text | Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy Cancers | Free Full-Text | Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy](https://pub.mdpi-res.com/cancers/cancers-15-03145/article_deploy/html/images/cancers-15-03145-ag.png?1687164916)
Cancers | Free Full-Text | Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
![PDF) Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms | Sofia Galli - Academia.edu PDF) Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms | Sofia Galli - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47272878/mini_magick20190207-32747-12ycgac.png?1549557851)
PDF) Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms | Sofia Galli - Academia.edu
![Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group | Leukemia Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.leu.2404521/MediaObjects/41375_2007_Article_BF2404521_Fig1_HTML.gif)
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group | Leukemia
![CONSORT Diagram. Abbreviations: STANDARD, Cytarabine 100 mg/m²/day by... | Download Scientific Diagram CONSORT Diagram. Abbreviations: STANDARD, Cytarabine 100 mg/m²/day by... | Download Scientific Diagram](https://www.researchgate.net/publication/330917523/figure/fig3/AS:958468777316352@1605528172163/CONSORT-Diagram-Abbreviations-STANDARD-Cytarabine-100mg-m-day-by-continuous-iv.png)
CONSORT Diagram. Abbreviations: STANDARD, Cytarabine 100 mg/m²/day by... | Download Scientific Diagram
![PDF) Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: Implications for a continuous infusion schedule PDF) Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: Implications for a continuous infusion schedule](https://i1.rgstatic.net/publication/13470893_Influence_of_fludarabine_on_pharmacokinetics_and_pharmacodynamics_of_cytarabine_Implications_for_a_continuous_infusion_schedule/links/5a87648eaca272017e5ab9a1/largepreview.png)
PDF) Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: Implications for a continuous infusion schedule
![Exposure to cytarabine causes side effects on adult development and physiology and induces intestinal damage via apoptosis in Drosophila - ScienceDirect Exposure to cytarabine causes side effects on adult development and physiology and induces intestinal damage via apoptosis in Drosophila - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223000537-gr9.jpg)